Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCurrys Regulatory News (CURY)

Share Price Information for Currys (CURY)

Share Price is delayed by 15 minutes
Get Live Data
163.60    4.00 (2.51%)
Bid:
162.40
Ask:
162.70
Spread: 0.30 (0.185%)
Market Cap: £1.70b
CURY Live PriceLast checked at - London Stock Exchange

Intraday Currys Share Chart

Director/PDMR Shareholding

1 Aug 2024 14:20

RNS Number : 8562Y
Currys PLC
01 August 2024
 

1 August 2024

CURRYS PLC

NOTIFICATION OF TRANSACTION OF DIRECTOR

Currys plc Buyout Award.

In accordance with the requirements of DTR 3.1 and Market Abuse Regulation Article 19, Currys plc (the 'Company') announces the following share transaction undertaken by Bruce Marsh, Group Chief Financial Officer (a PDMR).

Bruce exercised the first tranche of the Company granted Buyout Award A (the "Award") which was granted under Listing Rule 9.4.2(2) on 21 October 2021, and which then vested in full on 12 July 2024. The first tranche of the award became exercisable on the 12 July 2024. The exercise of the nil cost options over ordinary shares of 0.1 pence will be settled using market purchase shares.

Bruce exercised a total of 119,089 options, made up of 112,557 options and 6,532 accrued dividend equivalents and sold 56,169 shares to cover the tax liability arising on the transaction. The remaining 62,920 shares were retained.

PMDR DEALING NOTIFICATION

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Bruce Marsh

2

Reason for the notification

a)

Position/status

Group Chief Financial Officer

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer

a)

Name

Currys plc

b)

LEI

2138001E12GWLLDQQF16

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Ordinary shares of 0.1p each in Currys plc

Identification code

GB00B4Y7R145

b)

Nature of the transaction

Exercise of a share option granted under the Listing Rule 9.4.2(2) and sale of shares to cover the tax and NIC arising from the exercise

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil cost

119,089

£0.808

56,169

 

 

d)

Aggregated information

-

Aggregated volume

-

Price

1. Exercise

Price(s)

Volume(s)

Total

Nil cost

119,089

 £0.00

 

2. Sale

Price(s)

Volume(s)

Total

£0.808

56,169

 £45,384

e)

Date of the transaction

(DD-MM-YYYY)

31-07-2024

f)

Place of the transaction

London Stock Exchange (XLON)

 

Enquiries:

 

Sarah Thomas Deputy Company Secretary +44 (0)7401 373 188

 

Dan Homan Investor Relations Director +44 (0)7401 400 442

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBXGDIIBGDGSB
Date   Source Headline
1st Oct 20259:51 amRNSDirector/PDMR Shareholding
1st Oct 20257:00 amRNSTransaction in Own Shares
30th Sep 20257:00 amRNSTransaction in Own Shares
29th Sep 20257:00 amRNSTransaction in Own Shares
26th Sep 20257:00 amRNSTransaction in Own Shares
25th Sep 20257:00 amRNSTransaction in Own Shares
24th Sep 20257:00 amRNSTransaction in Own Shares
23rd Sep 20257:00 amRNSTransaction in Own Shares
22nd Sep 20257:00 amRNSTransaction in Own Shares
19th Sep 202511:02 amRNSBoard committee change
19th Sep 20257:00 amRNSTransaction in Own Shares
18th Sep 20257:00 amRNSTransaction in Own Shares
17th Sep 20257:00 amRNSTransaction in Own Shares
16th Sep 20257:00 amRNSTransaction in Own Shares
15th Sep 20257:00 amRNSTransaction in Own Shares
12th Sep 20257:00 amRNSTransaction in Own Shares
11th Sep 20257:00 amRNSTransaction in Own Shares
10th Sep 20257:00 amRNSTransaction in Own Shares
9th Sep 20257:00 amRNSTransaction in Own Shares
8th Sep 202511:20 amRNSDirector/PDMR Shareholding
8th Sep 20257:00 amRNSTransaction in Own Shares
5th Sep 20257:00 amRNSTransaction in Own Shares
4th Sep 20252:11 pmRNSResult of AGM
4th Sep 20257:00 amRNSAppointment of Rune Bjerke
4th Sep 20257:00 amRNSLaunch of £50m Share Buyback Programme
4th Sep 20257:00 amRNSStrong start to year, new £50m share buyback
1st Sep 20251:36 pmRNSTotal Voting Rights
20th Aug 20259:33 amRNSDirector/PDMR Shareholding
12th Aug 20252:41 pmRNSDirector/PDMR Shareholding
1st Aug 20259:30 amRNSTotal Voting Rights
31st Jul 20252:51 pmRNSDirector/PDMR Shareholding
31st Jul 202512:28 pmRNSHolding(s) in Company
31st Jul 202510:38 amRNSAnnual Financial Report
28th Jul 20252:02 pmRNSDirector/PDMR Shareholding
23rd Jul 20254:33 pmRNSDirector/PDMR Shareholding
23rd Jul 202511:15 amRNSDirector/PDMR Shareholding
8th Jul 20257:00 amRNSAppointment of Joint Corporate Broker
3rd Jul 20257:00 amRNSStrengthening performance drives profit & cashflow
1st Jul 20251:18 pmRNSDirectorate Change
1st Jul 20258:10 amRNSTotal Voting Rights
12th Jun 20253:02 pmRNSHolding(s) in Company
3rd Jun 20254:19 pmRNSHolding(s) in Company
2nd Jun 202510:56 amRNSTotal Voting Rights
21st May 20257:00 amRNSFY Trading - Performance continues to strengthen
19th May 20253:23 pmRNSHolding(s) in Company
16th May 20253:43 pmRNSHolding(s) in Company
9th May 202510:00 amRNS-RYellowstone Advisory Private Investor Evening
1st May 20258:41 amRNSTotal Voting Rights
29th Apr 20254:37 pmRNSHolding(s) in Company
4th Apr 20251:43 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.